Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
HCC1500 Cediranib
0.01
VEGFR/cKIT
RTK
 1.0574 -0.00310
HCC1500 Cediranib
0.001
VEGFR/cKIT
RTK
 0.9952 0.00629
CAMA-1 Cediranib
10.0
VEGFR/cKIT
RTK
 -0.2923 0.41992
T47D Cediranib
0.001
VEGFR/cKIT
RTK
 1.0199 -0.00080
HCC1500 Cediranib
0.031623
VEGFR/cKIT
RTK
 1.2029 -0.00553
MCF7 Cediranib
0.01
VEGFR/cKIT
RTK
 1.0466 -0.00064
MCF7 Cediranib
0.0031623
VEGFR/cKIT
RTK
 1.0519 -0.00143
Hs 578T Cediranib
3.1623
VEGFR/cKIT
RTK
 0.1560 0.19759
Hs 578T Cediranib
10.0
VEGFR/cKIT
RTK
 -0.5723 0.81093
T47D Cediranib
0.031623
VEGFR/cKIT
RTK
 1.0481 -0.00119
T47D Cediranib
0.01
VEGFR/cKIT
RTK
 1.0474 -0.00177
T47D Cediranib
1.0
VEGFR/cKIT
RTK
 0.9308 0.00485
CAL-120 Cediranib
10.0
VEGFR/cKIT
RTK
 -0.1243 0.32979
T47D Cediranib
10.0
VEGFR/cKIT
RTK
 -0.6403 0.66759
SK-BR-3 Cediranib
0.001
VEGFR/cKIT
RTK
 0.9992 0.00168
CAMA-1 Cediranib
0.0031623
VEGFR/cKIT
RTK
 0.9554 0.00549
CAMA-1 Cediranib
0.001
VEGFR/cKIT
RTK
 0.9400 0.00343
CAL-120 Cediranib
3.1623
VEGFR/cKIT
RTK
 0.2865 0.09105
PDXHCI002 Cediranib
0.31623
VEGFR/cKIT
RTK
 0.7860 0.01648
PDXHCI002 Cediranib
0.1
VEGFR/cKIT
RTK
 0.9039 0.00132
CAL-120 Cediranib
1.0
VEGFR/cKIT
RTK
 0.4489 0.05346
CAL-120 Cediranib
0.31623
VEGFR/cKIT
RTK
 0.7115 0.01885
MDA-MB-361 Cediranib
0.031623
VEGFR/cKIT
RTK
 0.9933 -0.00860
MDA-MB-361 Cediranib
0.31623
VEGFR/cKIT
RTK
 0.8244 -0.00465
MDA-MB-361 Cediranib
3.1623
VEGFR/cKIT
RTK
 0.2372 0.04747